DBV Technologies (DBVT) Receivables (2015 - 2023)
DBV Technologies (DBVT) reported Receivables of $1.4 million for Q4 2023, down 10.04% year-over-year from $1.5 million in Q4 2022, and down 10.04% quarter-over-quarter from $1.5 million in Q4 2022.
DBV Technologies (DBVT) Receivables (2015 - 2023) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Receivables data on file, last reported at $1.4 million in Q4 2023.
- Receivables for Q4 2023 came in at $1.4 million, down 10.04% year-over-year; the trailing twelve-month figure through Dec 2023 was $1.4 million (down 10.04% YoY), and the FY2023 annual result was $1.4 million, down 10.04% from the prior year.
- Receivables slipped to $1.4 million in Q4 2023 per DBVT's latest filing, from $1.5 million in the prior quarter.
- Over five years, Receivables peaked at $2.8 million in Q4 2020 and troughed at $1.3 million in Q4 2021.
- A 4-year average of $1.7 million and a median of $1.4 million in 2022 frame the typical range for Receivables.
- The sharpest annual moves came in 2021 and 2022: Receivables tumbled 54.39% in 2021, then rose 17.32% in 2022.
- A 4-year view of Receivables shows it stood at $2.8 million in 2020, then plunged by 54.39% to $1.3 million in 2021, then rose by 17.32% to $1.5 million in 2022, then slipped by 10.04% to $1.4 million in 2023.
- Business Quant data shows DBVT's Receivables at $1.4 million in Q4 2023, $1.5 million in Q4 2022, and $1.3 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 1.28 Mn |
| Dec 31, 2020 | 2.81 Mn |
| Dec 31, 2017 | 2.89 Mn |
| Dec 31, 2016 | 3.40 Mn |
| Dec 31, 2015 | 1.56 Mn |